Live Breaking News & Updates on Scientific advice

Stay informed with the latest breaking news from Scientific advice on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Scientific advice and stay connected to the pulse of your community

Form 10-K Jaguar Health, Inc. For: Dec 31

Form 10-K Jaguar Health, Inc. For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nigeria , Brazil , Kenya , Jordan , Russia , Italy , State-of-delaware , Delaware , United-states , California , Beijing , China

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

As previously announced, planning is underway with FDA to advance ibezapolstat into international Phase 3 clinical trials for treatment of C. difficile Infection As anticipated, an End of Phase 2...

United-states , America , Davidp-luci , Prnewswire-acurx-pharmaceuticals-inc , Company-scientific-advisory-board , Acurx-pharmaceuticals , European-medicines-agency , Exchange-commission-on-form , Society-or-healthcare-epidemiology-of-america , Drug-administration , Data-monitoring-committee

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Davidp-luci , Robertj-deluccia , Trial-oversight-committee , Acurx-pharmaceuticals-inc , Nasdaq , Data-monitoring-committee , Company-scientific-advisory-board , European-medicines-agency-on , Drug-administration , Acurx-pharmaceuticals

Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea

SAN FRANCISCO - Jaguar Health today announced that Jaguar family company Napo Pharmaceuticals has submitted an Orphan Drug Designation application to the U.S. Food and Drug Administration for...

Milan , Lombardia , Italy , United-states , Bangladesh , Italian , Steven-king , Magdalena-biosciences , Centers-for-disease , Jaguar-health , Filament-health-corp , Jaguar-health-inc

Strategies For Seeking Multiregional Regulatory Approval

Strategies For Seeking Multiregional Regulatory Approval
clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.

Peter-embley , National-library-of-medicine , Regulatory-authority-engagement , International-coalition-of-medicines-regulatory-authorities , Dip-reg-aff , Regulatory-guidance , Medium-enterprise , For-alignment-between-regulatory , International-coalition , Medicines-regulatory-authorities , Scientific-advice , Accelerated-pathways

Jaguar Health (JAGX) Announces Submission of Orphan Drug Designation Application to FDA for Crofelemer for Cholera-Related Diarrhea

Jaguar Health (JAGX) Announces Submission of Orphan Drug Designation Application to FDA for Crofelemer for Cholera-Related Diarrhea
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bangladesh , United-states , Steven-king , Centers-for-disease , Drug-administration , Napo-pharmaceuticals , European-union , International-centre-for-diarrhoeal-disease-research , Us-department-of-health-human-services , World-health-organization , Jaguar-health , European-medicines-agency

Jaguar Health, Inc.: Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea

Jaguar Health, Inc.: Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Italy , United-states , Milan , Lombardia , Bangladesh , Italian , Magdalena-biosciences , Steven-king , Jaguar-entheogen-therapeutics-initiative , Napo-pharmaceuticals , Drug-administration , Jaguar-health-inc

Nanoscope Therapeutics Provides Regulatory Update on MCO-010 for the Treatment of Retinitis Pigmentosa

Nanoscope Therapeutics Provides Regulatory Update on MCO-010 for the Treatment of Retinitis Pigmentosa
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dallas , Texas , United-states , Sulagna-bhattacharya , Icelandic-medicines-agency , Nanoscope-therapeutics-inc , Drug-administration , Scientific-advice , Typeb-end-of-phase ,

MCO-010 Gene Therapy for Retinitis Pigmentosa Receives Regulatory Feedback

Both the FDA and EU regulators indicated visual acuity may serve as primary endpoint to evaluate MCO-010 in the treatment of low-vision retinitis pigmentosa patients.

Sulagna-bhattacharya , Nanoscope-therapeutics-inc , Icelandic-medicines-agency , Drug-administration , Multi-characteristic-opsin , Typeb-end-of-phase , Scientific-advice ,

Nanoscope Therapeutics Provides Regulatory Update on MCO-010 for the Treatment of Retinitis Pigmentosa

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for...

Dallas , Texas , United-states , Sulagna-bhattacharya , Icelandic-medicines-agency , Drug-administration , Nanoscope-therapeutics-inc , Therapeutics-provides-regulatory-update , Scientific-advice , Typeb-end-of-phase ,